Pulse Biosciences (PLSE)

Common Shares
Sell: $21.58|Buy: $22.89|Change: 0.27 (1.27%)

Company profile

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

Address

3957 Point Eden Way
Hayward
CA
USA
94545


Telephone

+1 510 906-4600


Sector 

Healthcare


Previous key dates

NameKey Date
Pulse Biosciences Inc Annual Report for 20252026-03-19T00:00:00
Oppenheimer 36th Annual Healthcare MedTech & Services Conference2026-03-18T10:40:00
46TH ANNUAL TD COWEN HEALTHCARE CONFERENCE2026-03-04T13:10:00
Pulse Biosciences Inc Fourth Quarter Earnings Conference Call for 20252026-02-19T16:30:00
Pulse Biosciences Inc Fourth Quarter Earnings Result for 20252026-02-19T00:00:00
44th Annual J.P. Morgan 2026 Healthcare Conference2026-01-14T15:45:00
Pulse Biosciences Inc Annual General Meeting for 20252025-12-09T11:00:00
Piper Sandler 37th Annual Healthcare Conference 20252025-12-03T09:50:00
Stifel 2025 Healthcare Conference2025-11-13T14:40:00
Pulse Biosciences Inc Third Quarter Earnings Conference Call for 20252025-11-05T16:30:00
Pulse Biosciences Inc Third Quarter Earnings Result for 20252025-11-05T00:00:00
45th Canaccord Genuity Annual Growth Conference2025-08-13T11:00:00
Pulse Biosciences Inc Second Quarter Earnings Conference Call for 20252025-08-12T16:30:00
Pulse Biosciences Inc Second Quarter Earnings Result for 20252025-08-12T00:00:00
BofA Securities 2025 Health Care Conference2025-05-14T17:00:00
Pulse Biosciences Inc First Quarter Earnings Conference Call for 20252025-05-08T16:30:00
Pulse Biosciences Inc First Quarter Earnings Results for 20252025-05-08T00:00:00
24th Annual Needham Virtual Health Care Conference2025-04-10T09:30:00
Pulse Biosciences Inc Annual Report for 20242025-03-31T00:00:00
Pulse Biosciences Inc Fourth Quarter Earnings Conference Call for 20242025-03-27T16:30:00
Pulse Biosciences Inc Fourth Quarter Earnings Result for 20242025-03-27T00:00:00
TD Cowen 45th Annual Health Care Conference2025-03-05T10:30:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.